Twin Peaks Wealth Advisors’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
Twin Peaks Wealth Advisors's LMAT Position: Q2 2026 in Review
Twin Peaks Wealth Advisors sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 78 shares — an estimated $8.52K sold.
Twin Peaks Wealth Advisors first reported a position in LMAT in Q2 2025 and held it in 2 quarters. The position peaked at $8.52K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Twin Peaks Wealth Advisors reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
- Twin Peaks Wealth Advisors sold 78 LeMaitre Vascular shares in Q2 2026, an estimated $8.52K.
- Twin Peaks Wealth Advisors first reported a position in LeMaitre Vascular in Q2 2025 and held it in 2 quarters.
- Twin Peaks Wealth Advisors's LeMaitre Vascular position peaked at $8.52K in Q1 2026.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.